Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology

Clinical Trials: Hematologic Neoplasms


A listing of clinical trials currently looking for volunteers to enroll in Hematologic Neoplasms studies. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Phoenix : Investigational Site Number 840007

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Scottsdale : Mayo Clinic Arizona - Cancer Clinical Research Unit

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Scottsdale : Site Reference ID/Investigator# 59324

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Scottsdale : Investigational Site Number 840003

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Scottsdale : Investigational Site Number 840008

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Arkansas

Fayetteville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Little Rock : Call for Information (Investigational Site 0385)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Rogers : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

California

Anaheim : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Bakersfield : Call for Information (Investigational Site 0326)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Berkeley : Call for Information (Investigational Site 0015)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Burbank : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Burbank : Call for Information (Investigational Site 0324)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Campbell : Call for Information (Investigational Site 0312)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Fair Oaks : Call for Information (Investigational Site 0380)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Highland : Call for Information (Investigational Site 0430)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

La Jolla : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

La Jolla : Call for Information (Investigational Site 0251)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

La Jolla : University of California, San Diego

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

La Jolla : Investigational Site Number 840004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Los Angeles : Childrens Hospital Los Angeles

A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Los Angeles : Division Of Hematology & Oncology Ctr. For Health Sciences

Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy

Los Angeles : Investigational Site Number 840005

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Mission Hills : Call for Information (Investigational Site 0252)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Mission Hills : Call for Information (Investigational Site 0121)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Palo Alto : Investigational Site Number 840011

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Pleasant Hill : Call for Information (Investigational Site 0381)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Pleasant Hill : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Rancho Mirage : Call for Information (Investigational Site 0350)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

San Diego : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

San Diego : UCSD Moores Cancer Research Institute

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

San Francisco : Investigational Site Number 840005

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

San Francisco : Investigational Site Number 840004

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

San Francisco : Investigational Site Number 840003

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Santa Barbara : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Stanford : Stanford Cancer Center - Stanford University

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Stanford : Call for Information (Investigational Site 0341)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Stockton : Call for Information (Investigational Site 0242)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Colorado

Aurora : Call for Information (Investigational Site 0444)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Denver : RMCC

A Phase I Dose-Escalation and PK Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Englewood : Call for Information (Investigational Site 0304)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Connecticut

New Haven :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

New Haven : Yale Comprehensive Cancer Center at Yale University School of Medicine

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Torrington : Call for Information (Investigational Site 0376)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Delaware

Newark : Call for Information (Investigational Site 0274)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

District of Columbia

Washington : Call for Information (Investigational Site 0309)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Washington : Call for Information (Investigational Site 0424)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Washington : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Florida

Boynton Beach : Call for Information (Investigational Site 0266)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Boynton Beach : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Coral Gables : Call for Information (Investigational Site 0340)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Gainesville : University of Florida College of Medicine

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

Hialeah : Call for Information (Investigational Site 0020)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Jacksonville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Jacksonville : Call for Information (Investigational Site 0267)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Jacksonville : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Lakeland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Lakeland : Call for Information (Investigational Site 0384)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0028)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0206)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0243)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0284)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0268)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0278)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Miami : Call for Information (Investigational Site 0365)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Orlando : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Orlando : Call for Information (Investigational Site 0429)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Orlando : Call for Information (Investigational Site 0419)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Port St. Lucie : Call for Information (Investigational Site 0259)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Sarasota :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Stuart : Call for Information (Investigational Site 0339)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Tampa : Moffitt Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

West Palm Beach : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Georgia

Atlanta : Emory

A Phase I Dose-Escalation and PK Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Atlanta : Call for Information (Investigational Site 0437)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Atlanta : Site Reference ID/Investigator# 26523

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Atlanta : Winship Cancer Institute, Emory University

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Atlanta : Investigational Site Number 840005

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

View More »

Dublin : Call for Information (Investigational Site 0271)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Savannah : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Hawaii

Honolulu : Call for Information (Investigational Site 0235)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Illinois

Chicago : Call for Information (Investigational Site 0023)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Chicago : Call for Information (Investigational Site 0024)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Chicago : Call for Information (Investigational Site 0454)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Decatur : Call for Information (Investigational Site 0285)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Harvey : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

View More »

Joliet : Call for Information (Investigational Site 0407)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Joliet : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Maywood : Call for Information (Investigational Site 0273)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Maywood : Loyola University Medical Center, Cardinal Bernardin Cancer Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Maywood : Loyola University Medical Center

Umbilical Cord Transplantation for the Elderly Population

Niles : Call for Information (Investigational Site 0018)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Peoria : Call for Information (Investigational Site 0277)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Rockford : Call for Information (Investigational Site 0443)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Skokie : Call for Information (Investigational Site 0303)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Skokie : Call for Information (Investigational Site 0386)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Skokie : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Urbana : Call for Information (Investigational Site 0205)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Indiana

Anderson : Call for Information (Investigational Site 0025)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Anderson : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Avon : Call for Information (Investigational Site 0257)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Evansville : Call for Information (Investigational Site 0011)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Fort Wayne : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

View More »

Indianapolis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Indianapolis : Call for Information (Investigational Site 0427)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Indianapolis : Quality Oncology Care, Inc.

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Indianapolis : Community Regional Cancer Center-Community Hospital North

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

Indianapolis : Indiana University Simon Cancer Center

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Kokomo : Call for Information (Investigational Site 0442)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Martinsville : Morgan Hospital and Medical Center

Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes

New Albany : Call for Information (Investigational Site 0396)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

South Bend : Call for Information (Investigational Site 0395)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Iowa

Ames : Call for Information (Investigational Site 0249)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Cedar Rapids : Call for Information (Investigational Site 0360)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Cedar Rapids : Call for Information (Investigational Site 0286)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Des Moines : Call for Information (Investigational Site 0197)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Waterloo : Call for Information (Investigational Site 0382)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Kansas

Kansas City : Investigational Site Number 840001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Wichita : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Wichita : Call for Information (Investigational Site 0199)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Kentucky

Paducah : Call for Information (Investigational Site 0269)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Paducah : Call for Information (Investigational Site 0283)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Paducah : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Louisiana

Covington : Call for Information (Investigational Site 0310)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Metairie : Call for Information (Investigational Site 0275)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New Orleans : Call for Information (Investigational Site 0200)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Maine

Lewiston : Call for Information (Investigational Site 0293)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Scarborough : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Maryland

Annapolis : Call for Information (Investigational Site 0397)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Baltimore : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Baltimore : Call for Information (Investigational Site 0302)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Baltimore : Call for Information (Investigational Site 0247)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Baltimore : Call for Information (Investigational Site 0318)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Baltimore : Call for Information (Investigational Site 0400)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Baltimore : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Baltimore : Investigational Site Number 840013

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Baltimore : Sidney Kimmel Comprehensive Cancer Center

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Bethesda : Call for Information (Investigational Site 0012)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Bethesda : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Frederick : Call for Information (Investigational Site 0279)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Westminster : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Massachusetts

Boston : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Boston : Tufts-New England Medical Center

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Boston : Dana Farber Cancer Institute

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Michigan

Ann Arbor : Investigational Site Number 840010

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Detroit : Call for Information (Investigational Site 0229)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Detroit : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Lansing : Call for Information (Investigational Site 0383)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Minnesota

Duluth : Call for Information (Investigational Site 0282)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Minneapolis : Call for Information (Investigational Site 0022)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Minneapolis : Novartis Investigative Site

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies

Minneapolis : University of Minnesota: Masonic Cancer Center, BMT Clinic, and Fairview Medical Center

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Rochester : Mayo Clinic

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

View More »

Rochester : Investigational Site Number 840007

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

St. Cloud : Call for Information (Investigational Site 0202)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Missouri

Saint Louis : Call for Information (Investigational Site 0150)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Saint Louis : Call for Information (Investigational Site 0294)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Springfield : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Springfield : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

St Louis : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

View More »

St Louis : Investigational Site Number 840003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

St. Louis : Washington University School of Medicine Division of Oncology

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Montana

Billings : Call for Information (Investigational Site 0368)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Billings : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Great Falls : Call for Information (Investigational Site 0378)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Missoula : Call for Information (Investigational Site 0349)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Nebraska

Lincoln : Call for Information (Investigational Site 0240)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Lincoln : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Omaha : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Omaha : Call for Information (Investigational Site 0256)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Nevada

Las Vegas : Call for Information (Investigational Site 0387)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New Hampshire

Dover : Call for Information (Investigational Site 0204)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New Jersey

Camden : Call for Information (Investigational Site 0448)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Denville : Call for Information (Investigational Site 0196)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Hackensack : HUMC

A Phase I Dose-Escalation and PK Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Hackensack : Research Site

AMG 319 Lymphoid Malignancy FIH

Hackensack : John Theurer Cancer Center at Hackensack University

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

View More »

Hackensack : John Theurer Cancer Center

Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy

Newark : Investigational Site Number 840006

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Somerville : Call for Information (Investigational Site 0327)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New York

Commack : Call for Information (Investigational Site 0263)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

East Syracuse : Call for Information (Investigational Site 0033)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Great Neck : Call for Information (Investigational Site 0258)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Great Neck : Call for Information (Investigational Site 0234)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Lake Success : Call for Information (Investigational Site 0230)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Manhasset : Call for Information (Investigational Site 0233)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New York : Memorial Sloan Kettering Cancer Center

A First-in-Human Phase 1 and Expanded Cohort Study of EPZ-5676 in Advanced Hematologic Malignancies, Including Acute Leukemia With Rearrangement of the MLL Gene

New York :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

New York : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

New York : Call for Information (Investigational Site 0370)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New York : Call for Information (Investigational Site 0409)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New York : Call for Information (Investigational Site 0408)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New York : Investigational Site Number 840009

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

New York : Memorial Sloan Kettering Cancer Ctr

Safety Study of Anti-Programmed Death-1 in Hematologic Malignancy

New York City : Cornell

A Phase I Dose-Escalation and PK Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Rochester : Call for Information (Investigational Site 0198)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Stony Brook : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

North Carolina

Charlotte : Call for Information (Investigational Site 0014)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Durham : Research Site

AMG 319 Lymphoid Malignancy FIH

Durham : Pediatric Bone and Cord Blood, Duke Univ. Med. Center

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Fayetteville : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Gastonia : Call for Information (Investigational Site 0375)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

High Point : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Wilmington : Call for Information (Investigational Site 0432)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Winston-Salem : Call for Information (Investigational Site 0315)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

North Dakota

Bismarck : Call for Information (Investigational Site 0030)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Bismarck : Call for Information (Investigational Site 0224)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Bismarck : Call for Information (Investigational Site 0305)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Bismarck : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Fargo : Call for Information (Investigational Site 0153)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Fargo : Call for Information (Investigational Site 0301)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Ohio

Akron : Call for Information (Investigational Site 0250)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Akron : Call for Information (Investigational Site 0323)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Canton : Call for Information (Investigational Site 0422)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Canton : Investigational Site Number 840011

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Cincinnati : Investigational Site Number 840004

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

View More »

Cleveland : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Cleveland : Cleveland Clinic, Taussig Cancer Institute

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Case Western Reserve University, University Hospitals of Cleveland

Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic Malignancy

Cleveland : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Columbus : OSU

A Phase I Dose-Escalation and PK Study of TG02 Citrate in Patients With Advanced Hematological Malignancies

Columbus : The Ohio State University Comprehensive Cancer Center

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Columbus : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Columbus : Call for Information (Investigational Site 0019)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Columbus : Ohio State University Comprehensive Cancer Center - The James

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Columbus : The Ohio State University

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

Middletown : Investigational Site Number 840019

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Toledo : Call for Information (Investigational Site 0399)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Oklahoma

Oklahoma City : Call for Information (Investigational Site 0325)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Oregon

Beaverton : Call for Information (Investigational Site 0401)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Pennsylvania

Bethlehem : Call for Information (Investigational Site 0417)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Philadelphia : Call for Information (Investigational Site 0021)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Philadelphia : Call for Information (Investigational Site 0026)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Philadelphia : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Sayre : Call for Information (Investigational Site 0346)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

West Reading : Call for Information (Investigational Site 0016)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

West Reading : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Willow Grove : Call for Information (Investigational Site 0248)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

South Carolina

Charleston : Call for Information (Investigational Site 0316)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Charleston : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Charleston : Investigational Site Number 840009

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

South Dakota

Rapid City : Call for Information (Investigational Site 0241)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Sioux Falls : Call for Information (Investigational Site 0151)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Watertown : Call for Information (Investigational Site 0225)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Tennessee

Germantown : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Germantown : Call for Information (Investigational Site 0405)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Nashville :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Nashville : Sarah Cannon Research Institute

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Nashville : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

View More »

Nashville : Investigational Site Number 840001

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Nashville : Tennessee Oncology, PLLC

Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies

Texas

Amarillo : Call for Information (Investigational Site 0295)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Amarillo : Texas Oncology

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Austin : Call for Information (Investigational Site 0404)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Corpus Christi : Call for Information (Investigational Site 0372)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Corpus Christi : Call for Information (Investigational Site 0406)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Dallas : Mary Crowley Cancer Research Centers - Medical City

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Dallas : Call for Information (Investigational Site 0366)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Galveston : Call for Information (Investigational Site 0027)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Houston :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Houston : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

Houston : Call for Information (Investigational Site 0355)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Houston : Call for Information (Investigational Site 0255)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Houston : Site Reference ID/Investigator# 26522

ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic Malignancies

Houston : Investigational Site Number 840002

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Houston : Research Site

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Leukemias and Related Disorders

Houston : MD Anderson Cancer Center

Study of KB004 in Subjects With Hematologic Malignancies

Houston : Investigational Site Number 840001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Houston : University of Texas - MD Anderson Cancer Center

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Killeen : Call for Information (Investigational Site 0314)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Lubbock : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Lubbock : Call for Information (Investigational Site 0272)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

New Braunfels : Call for Information (Investigational Site 0441)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Round Rock : Call for Information (Investigational Site 0245)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

San Antonio : Call for Information (Investigational Site 0317)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

San Antonio : Call for Information (Investigational Site 0300)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

San Antonio : Methodist Hospital - Texas Transplant Institute

A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies

Temple : Call for Information (Investigational Site 0034)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Temple : Call for Information (Investigational Site 0343)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Utah

Ogden : Call for Information (Investigational Site 0239)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Salt Lake City : Huntsman Cancer Center, University of Utah

A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies

Salt Lake City : Call for Information (Investigational Site 0313)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Salt Lake City : Investigational Site Number 840002

Dose Escalation Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies

Virginia

Charlottesville : University of Virginia Health System

A Study of CDX-1127 in Patients With Select Solid Tumor Types or Hematologic Cancers

Washington

Seattle : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Seattle : Pfizer Investigational Site

A Study Of PF-04449913 In Select Hematologic Malignancies

Seattle : Call for Information (Investigational Site 0347)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Seattle : Fred Hutchinson Cancer Research Center

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Seattle : Seattle Cancer Care Alliance

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

View More »

Tacoma : Call for Information (Investigational Site 0029)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Tacoma : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Wenatchee : Call for Information (Investigational Site 0428)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

West Virginia

Morgantown : Call for Information (Investigational Site 0270)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Wisconsin

Green Bay : Call for Information (Investigational Site 0122)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Green Bay : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

La Crosse : Call for Information (Investigational Site 0236)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Madison :

A Phase 1 Study of IPI-145 in Patients With Advanced Hematologic Malignancies

Madison : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

View More »

Madison : Call for Information (Investigational Site 0311)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Madison : University of Wisconsin

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Argentina

Buenos Aires : Merck Sharp & Dohme (Argentina) Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Australia

Adelaide : Royal Adelaide Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Clayton : Investigational Site Number 036001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Douglas : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Garran : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Hobart : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

View More »

Kingswood : Investigational Site Number 036002

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Kogarah : Investigational Site Number 036004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Liverpool : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Malvern : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Melbourne : GSK Investigational Site

Continuation Study of the Oral AKT Inhibitor GSK2110183

Nedlands : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Parkville : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Prahran : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Prahran : The Alfred Hospital

Study of KB004 in Subjects With Hematologic Malignancies

Randwick : Investigational Site Number 036003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

South Brisbane : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

South Granville : Merck Sharp & Dohme (Australia) Pty Ltd.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Tweed Heads : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Wodonga : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Austria

Innsbruck : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Salzburg : Investigational Site Number 040002

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Vienna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Vienna : Merck Sharp & Dohme Gmbh

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Wien : Investigational Site Number 040001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Brazil

Sao Paulo : Merck Sharp & Dohme Farmaceutica Ltda.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Bulgaria

Sofia : Merck Sharp & Dohme IDEA Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Canada

Barrie : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Burnaby : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Halifax : Queen Elizabeth II Health Sciences Centre

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Hamilton : Juravinski Hospital & Cancer Centre

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Kirkland : Merck Frosst Canada Ltd.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

View More »

Laval : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Moncton : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Montreal : Hôpital Maisonneuve-Rosemont

A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing

Montreal : Investigational Site Number 124002

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Montreal : Hopital Maisonneuve-Rosemont

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Newmarket : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Quebec : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Toronto : GSK Investigational Site

Continuation Study of the Oral AKT Inhibitor GSK2110183

Toronto : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Toronto : Investigational Site Number 124001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Toronto : Investigational Site Number 124003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Vancouver : Investigational Site Number 124001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Vancouver : Vancouver General Hospital

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Windsor : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Winnipeg : CancerCare Manitoba

Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation

Chile

Santiago : Merck Sharp & Dohme (I.A.) Corp.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Colombia

Bogota : Frosst Laboratories Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Croatia

Zagreb : Merck Sharp & Dohme IDEA, Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Czech Republic

Brno : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Ostrava-Poruba : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Praha 10 : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Ecuador

Quito : Merck Sharp and Dohme (I.A.) Corp. Ecuador

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

France

Brest : Investigational Site Number 250004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Caen Cedex : Investigational Site Number 250005

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Le Mans : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Le Mans Cedex 9 : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Lille : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

View More »

Lille Cedex : Investigational Site Number 250002

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Lyon : Centre Hospitalier Lyon Sud

Phase I Study of mPEG-R-Crisantaspase Given IV

Lyon Cedex : Hospital Edouard Herriot, Service d'Hematologie Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Marseille : Investigational Site Number 250001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Marseille : Investigational Site Number 250003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Marseille cedex 5 : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Nantes : Hospital Hotel Dieu, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Nantes Cedex 1 : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Nice Cedex 3 : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Nimes Cedex 9 : Investigational Site Number 250003

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Paris : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Paris : Investigational Site Number 250006

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Paris : Hospital Saint Louis, Service D'Hematologie

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Paris Cedex 10 : Investigational Site Number 250002

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Paris Cedex 10 : Investigational Site Number 250001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Paris Cedex 12 : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Pessac : CHU du Haut-Leveque, Service des Matadies du Sang Unite de Recherche Clinique

Trial of Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase (MEK) Inhibitor

Pessac Cedex : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Rouen : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Strasbourg : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Toulouse : Investigational Site Number 250004

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Villefranche Sur Saone Cedex : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Germany

Aachen : Investigational Site Number 276002

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Ahaus : Facharzt für Innere Medizin, Onkologie, Hämatologie

Nivestim(TM) in Treatment of Malignant Diseases

Bad Sackingen : "Facharzt für Innere Medizin

Nivestim(TM) in Treatment of Malignant Diseases

Berlin : MediOnko-Institut GbR

Nivestim(TM) in Treatment of Malignant Diseases

Berlin : Onkoplan GmbH/Onkologische Schwerpunkpraxis

Nivestim(TM) in Treatment of Malignant Diseases

View More »

Berlin : Facharzt für Innere Medizin - onkologische Schwerpunktpraxis

Nivestim(TM) in Treatment of Malignant Diseases

Berlin : Investigational Site Number 276004

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Billerbeck : Onkologie Glados&Retzlaff&Glados GbR

Nivestim(TM) in Treatment of Malignant Diseases

Borken : Gemeinschaftspraxis - FA für innere Medizin

Nivestim(TM) in Treatment of Malignant Diseases

Brandenburg : Frauenarzt

Nivestim(TM) in Treatment of Malignant Diseases

Castrop Rauxel : Fachärztin für innere Medizin Hämatologin-Onkologin

Nivestim(TM) in Treatment of Malignant Diseases

Chemnitz : FA f. Frauenheilkunde und Geburtshilfe Gynakolgische Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Cottbus : Fachärztin für Innere Medizin / Hämatologie / Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Dortmund : Gesellschaft für onkologische Studien Dortmund mbH

Nivestim(TM) in Treatment of Malignant Diseases

Dresden : Gemeinschaftspraxis

Nivestim(TM) in Treatment of Malignant Diseases

Dusseldorf : Gemeinschaftspraxis Haematologie/Medizin Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Eisenach : Gemeinschaftspraxis

Nivestim(TM) in Treatment of Malignant Diseases

Essen : Praxis für Hämatologie/Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Frankfurt Am Main : Investigational Site Number 276003

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Frankfurt Am Main : Investigational Site Number 276004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Garbsen : Internist - Hämatologe - Onkologe

Nivestim(TM) in Treatment of Malignant Diseases

Gutersloh : Onkodok GmbH

Nivestim(TM) in Treatment of Malignant Diseases

Hannover : Internist - Hämatologe - Onkologe

Nivestim(TM) in Treatment of Malignant Diseases

Heidenheim : ODZ-Petersen GmbH

Nivestim(TM) in Treatment of Malignant Diseases

Herne : DOKUSAN Gesellschaft für medizinische Studien mbH & Co. KG

Nivestim(TM) in Treatment of Malignant Diseases

Holzkirchen : "Onkologie und Hämatologie Time-Share-Praxis/

Nivestim(TM) in Treatment of Malignant Diseases

Jena : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Jena : Investigational Site Number 276001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Koln : Büro für onkologische Dokumentation

Nivestim(TM) in Treatment of Malignant Diseases

Köln : Universiätsklinikum Köln

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Krefeld : ZAGO

Nivestim(TM) in Treatment of Malignant Diseases

Leipzig : Pneumologisch/onkologisch/internistisches Studienzentrum

Nivestim(TM) in Treatment of Malignant Diseases

Leipzig : Investigational Site Number 276007

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Lepzig : FA f. Frauenheilkunde und Geburtshilfe

Nivestim(TM) in Treatment of Malignant Diseases

Liepzeig : FA für Innere Medizin

Nivestim(TM) in Treatment of Malignant Diseases

Lippstadt : Fachübergreifende Gemeinschaftspraxis Innere Medizin, Hämatologie, Onkologie, Tumortherapie, Palliativmedizin

Nivestim(TM) in Treatment of Malignant Diseases

Magdeburg : Investigational Site Number 276006

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Mainz : Praxis für Innere Medizin, Hämatologie und Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Mannheim : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Mannheim : SPGO Research Mannheim Gmbh

Nivestim(TM) in Treatment of Malignant Diseases

Mannheim : Investigational Site Number 276001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Mannheim : Investigational Site Number 276003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Minden : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Minden : Johannes Esling Klinikum Minden

Nivestim(TM) in Treatment of Malignant Diseases

Moers : OnkoLog Moers GbR

Nivestim(TM) in Treatment of Malignant Diseases

Munchen : Innere Medizin, Hämatologie u. Intern. Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Munchen : Fachärzte für Innere Medizin - Hämatologie u. Internistische Onkologie - Bluttransfusionswesen

Nivestim(TM) in Treatment of Malignant Diseases

Munchen : Hämatologie und internistische Onkologie Facharzt für Innere Medizin

Nivestim(TM) in Treatment of Malignant Diseases

Munchen : Forschungs- und Studiengesellschaft HOPE München GmbH

Nivestim(TM) in Treatment of Malignant Diseases

Munster : Fachärzte für Innere Medizin Hämatologie u. internistische Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Neustadt/Sachsen : Facharzt für Innere Medizin - Medikamentöse Tumortherapie - Palliativmedizin

Nivestim(TM) in Treatment of Malignant Diseases

Nordhausen : MVZ Nordhausen gGmbH/ FA für Frauenheilkunde und Geburtshilfe

Nivestim(TM) in Treatment of Malignant Diseases

Nurnberg : Martha-Maria Krankenhaus gGmbH MVZ Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Oberhausen : Gynäkologische Praxisklinik

Nivestim(TM) in Treatment of Malignant Diseases

Oeide : Fachärztin für Innere Medizin Hämatologie u. Internistische Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Olpe : Medizinisches Versorgungszentrum Onkologische Schwerpunktpraxis

Nivestim(TM) in Treatment of Malignant Diseases

Osnabruck :

Nivestim(TM) in Treatment of Malignant Diseases

Paradiese : Medizinisches Versorgungszentrum GbR

Nivestim(TM) in Treatment of Malignant Diseases

Remscheid : Facharzt für Innere Medizin - Hämatologie - Onkologie - Medikamentöse Tumortherapie

Nivestim(TM) in Treatment of Malignant Diseases

Rodgau : Frauenärzte -Naturheilverfahren-

Nivestim(TM) in Treatment of Malignant Diseases

Siegburg : Onkol. Managementgesellschaft Bonn/Rhein-Sieg/Ahr mbH

Nivestim(TM) in Treatment of Malignant Diseases

Stralsund : g.SUND Gyn. Kompetenzzentrum FA f. Frauenheilkunde & Geburtshilfe SP Gynäkologie Onkologie operative Gyn./ med. Tumortherapie/ Palliativmed.

Nivestim(TM) in Treatment of Malignant Diseases

Stuttgart : Robert-Bosch-Krankenhaus

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Ulm : Investigational Site Number 276005

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Ulm : Investigational Site Number 276002

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Velbert : Fachärzte für Innere Medizin -Hämatologie und Internistische Onkologie

Nivestim(TM) in Treatment of Malignant Diseases

Witten : FA f. Frauenheilkunde u. Geburtshilfe Marien-Hospital Witten gGmbH

Nivestim(TM) in Treatment of Malignant Diseases

Würzburg : Universitätsklinikum Würzburg

Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)

Zittau : FA für innere Medizin/Hämatologie und Int. Onkologie/Palliativmedizin

Nivestim(TM) in Treatment of Malignant Diseases

Greece

Alimos : Vianex, S.A. / MSD

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Athens : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Heraklion : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Patra : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Thessaloniki : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Honduras

Tegucigalpa : Merck Sharp & Dohme (IA) Corp.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Hong Kong

Hong Kong : Merck Sharp & Dohme (Asia) Ltd.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Hungary

Budapest : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Debrecen : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Gyula : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Kaposvar : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Szeged : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Ireland

Dublin : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Italy

Ancona : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Aviano : centro Riferimento Oncologico (CRO), National Cancer Institute

Febuxostat for Tumor Lysis Syndrome Prevention in Hematologic Malignancies

Bergamo : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Bologna : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Bologna : Investigational Site Number 380003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

View More »

Catania : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Firenze : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Firenze : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Firenze : Investigational Site Number 380001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Milan : Merck Sharp & Dohme (Italia) S.P.A.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Napoli : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Novara : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Orbassano : Investigational Site Number 380004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Pescara : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Pisa : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Roma : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Torino : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Vicenza : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Vimercate MB : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Japan

Akita-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Fukuoka : Research site

A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Isehara : Research site

A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Kamogawa-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Kawagoe-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

View More »

Kumamoto-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Kyoto-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Maebashi-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Nagoya :

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Nagoya-shi : Research site

A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies

Nagoya-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Ogaki-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Okayama-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Shibukawa-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Shibuya-ku : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Tokushima-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Tokyo :

Phase I Study of OPB-51602 in Patients With Hematologic Malignancies

Toyama-shi : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Jordan

Amman : Merck Sharpe & Dohme Idea Inc.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Korea, Republic of

Daejeon : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Gwangju : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Incheon : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Seongnam : Investigational Site Number 410001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Seoul : GSK Investigational Site

Continuation Study of the Oral AKT Inhibitor GSK2110183

View More »

Seoul : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Seoul : Seoul National University Hospital

Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies

Seoul : Investigational Site Number 410004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Seoul : Investigational Site Number 410002

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Seoul : Investigational Site Number 410003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Lithuania

Vilnius : UAB Merck Sharp & Dohme

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Malaysia

Kuching : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Mexico

Mexico City : Merck Sharp & Dohme De Mexico, S.A. De C.V.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Netherlands

Amsterdam : Investigational Site Number 528002

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Nijmegen : Investigational Site Number 528001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

New Zealand

Christchurch : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Grafton, Auckland : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Newtown, Wellington : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Peru

Lima : Merck Sharp & Dohme, Peru S.R.L.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Philippines

Makati City : Merck Sharp & Dohme (I.A.) Corporation

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Poland

Warszawa : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Puerto Rico

San Juan : Call for Information (Investigational Site 0099)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

San Juan : Call for Information (Investigational Site 0228)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

San Juan : Call for Information (Investigational Site 0244)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Romania

Bucharest : MSD Bucharest

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Russian Federation

Nizhny Novgorod : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Petrozavodsk : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Singapore

Singapore : Merck Sharp & Dohme (Singapore)

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Singapore : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

South Africa

Pretoria : MSD (Pty) LTD South Africa

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Spain

Badalona : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Badalona : Investigational Site Number 724004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Barcelona : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Barcelona : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Barcelona : Investigational Site Number 724001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

View More »

Barcelona : Investigational Site Number 724001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Madrid : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Madrid : Merck Sharp & Dohme De Espana, S.A.E.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Madrid : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Madrid : Investigational Site Number 724003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Majadahonda : Investigational Site Number 724003

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

Ourense : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Palma de Mallorca : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Salamanca : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Salamanca : Investigational Site Number 724002

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

San Sebastián : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Sevilla : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Valencia : For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Valencia : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Valencia : Investigational Site Number 724002

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Sweden

Switzerland

Basel : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Chur : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Zurich : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Taiwan

Taichung : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Tainan : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Taipei : Merck Sharp & Dohme (I.A.) Corp.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Taipei : Research Site

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma

Turkey

Istanbul : Merck Sharp & Dohme Ilaclari Ltd. Sti

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

United Kingdom

Belfast : Investigational Site Number 826001

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Birmingham : Investigational Site Number 826006

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Glasgow : Investigational Site Number 826005

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

Hoddesdon : Merck Sharp & Dohme Ltd.

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011 AM2)

Leeds : Investigational Site Number 826007

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

View More »

London : Investigational Site Number 826001

Phase II, Open Label, Single Arm Study of SAR302503 In Myelofibrosis Patients Previously Treated With Ruxolitinib

London : King's College Hospital

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

London : University College London

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

London : Investigational Site Number 826004

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

London : Investigational Site Number 826003

Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia

London : Imperial College NHS Trust

WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation

Manchester : The Christie NHS Foundation

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Newcastle upon Tyne : University of Newcastle Upon Tyne, NHS Foundation Trust

Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies

Southampton : Southampton University Hospitals NHS Trust

WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation